BIEMANS Barbara,GUBA Wolfgang,JAESCHKE Georg,LINDEMANN Lothar,O'HARA Fionn,RICCI Antonio,RUEHER Daniel,VIEIRA Eric
申请号：
SI201630292
公开号：
SI3322701T1
申请日:
2016.07.11
申请国别(地区):
SI
年份:
2019
代理人:
摘要：
The present invention relates to positive allosteric modulators (PAMs) of metabotropic glutamate receptor 4 (mGluR4) that may be used for the treatment of conditions such as Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.
